Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study.

Yan ZhangJing-Lu JinYe-Xuan CaoHui-Hui LiuHui-Wen ZhangYuan-Lin GuoNa-Qiong WuYing GaoQi HuaYan-Fang LiRui-Xia XuChuan-Jue CuiGeng LiuQian DongJing SunJian-Jun Li

Published in: Journal of translational medicine (2020)

Combining Fib and Lp(a) enhance the prognostic value for incident CVEs beyond Lp(a) or Fib alone.

Keyphrases

coronary artery disease
liver fibrosis
cardiovascular disease
percutaneous coronary intervention
cardiovascular events
coronary artery bypass grafting
type diabetes
low density lipoprotein
aortic stenosis
left ventricular
aortic valve